You can find more information about
mitogen-activated protein kinase phosphatase 1, putative
using the following links:
PFID
PFID Old
Formal Annotation
PlasmoDB
TDR Targets
Subcellular Localization
Affecting Drugs
Drug Name
PubMed Articles (year of publication)
PF3D7_1305500
PF13_0027
mitogen-activated protein kinase phosphatase 1, putative
PlasmoDB
TDR
1-(4-chlorophenyl)-5-oxo-3-pyrrolidinecarboxylic acid
In silico characterization of an atypical MAPK phosphatase of Plasmodium falciparum as a suitable target for drug discovery
2-((n-[(4-fluorophenyl)(2-thienyl)methyl]glycyl)amino)-3-thiophenecarboxamide
In silico characterization of an atypical MAPK phosphatase of Plasmodium falciparum as a suitable target for drug discovery
2-([n-(diphenylmethyl)glycyl]amino)-3-thiophenecarboxamide
In silico characterization of an atypical MAPK phosphatase of Plasmodium falciparum as a suitable target for drug discovery
2-[(2e)-2-(1,3-benzodioxol-5-ylmethylene)hydrazino]-1h-benzimidazole
In silico characterization of an atypical MAPK phosphatase of Plasmodium falciparum as a suitable target for drug discovery
2-[(2e)-2-(3,4-bi-methoxybenzylidene)hydrazino]-1h-benzimidazole
In silico characterization of an atypical MAPK phosphatase of Plasmodium falciparum as a suitable target for drug discovery
3-[(e)-(1h-benzimidazol-2-ylhydrazono)methyl]-2-chloro-7-methoxyquinoline
In silico characterization of an atypical MAPK phosphatase of Plasmodium falciparum as a suitable target for drug discovery
BVT 948
Antiplasmodial drug targets: a patent review (2000 - 2013)
Knockout, suggested target
In silico characterization of an atypical MAPK phosphatase of Plasmodium falciparum as a suitable target for drug discovery
NSC 663,284
Antiplasmodial drug targets: a patent review (2000 - 2013)
NSC 87,877
Antiplasmodial drug targets: a patent review (2000 - 2013)
NSC 95,397
Antiplasmodial drug targets: a patent review (2000 - 2013)
Expasy - NiceZime View
Brenda - The Comprehensive Enzyme Information System